kinases protein kinase inhibitors signaling activators kinase substrates antibodies bioluminescence assays
ActiveMax® Recombinant Human TGF beta1 Protein, Tag Free, 2x 500 µg  

ActiveMax® Recombinant Human TGF beta1 Protein, Tag Free, 2x 500 µg

ActiveMax® Recombinant Human TGF-Beta 1 / TGFB1 Protein, Ala 279 - Ser 390, expressed from human 293 cells, Tag Free

Synonyms: TGFB1, CED, DPD1 LAP, TGFB, CEDLAP, TGF beta,TGF-β1,TGF-beta1, Human Transforming Growth Factor-beta-1

More details


Availability: within 7 days

3 090,00 €

Background: Transforming growth factor beta 1 ( TGFB1) is also known as TGF-β1, CED, DPD1, TGFB. is a polypeptide member of the transforming growth factor beta superfamily of cytokines. It is a secreted protein that performs many cellular functions, including the control of cell growth, cell proliferation, cell differentiation and apoptosis.[1] The TGFB1 protein helps control the growth and division (proliferation) of cells, the process by which cells mature to carry out specific functions (differentiation), cell movement (motility), and the self-destruction of cells (apoptosis). The TGFB1 protein is found throughout the body and plays a role in development before birth, the formation of blood vessels, the regulation of muscle tissue and body fat development, wound healing, and immune system function. TGFB1 is particularly abundant in tissues that make up the skeleton, where it helps regulate bone growth, and in the intricate lattice that forms in the spaces between cells (the extracellular matrix). Within cells, this protein is turned off (inactive) until it receives a chemical signal to become active.[2-3] TGFB1 plays an important role in controlling the immune system, and shows different activities on different types of cell, or cells at different developmental stages. Most immune cells (or leukocytes) secrete TGFB1. [4] TGFB1 has been shown to interact with TGF beta receptor 1, LTBP1, YWHAE, EIF3I and Decorin.

Recombinant ActiveMax® Human TGFB1, Tag Free (TG1-H4212) is expressed from human 293 cells (HEK293). It contains AA Ala 279 - Ser 390 (Accession # P01137-1). Predicted N-terminus: Ala 279

Molecular Characterization
This protein carries no "tag". The protein has a calculated MW of 12.8 kDa (monomer). the protein migrates as 14 kDa (monomer) under reducing (R) condition, and 25 kDa (Dimer) under non-reducing (NR) condition (SDS-PAGE).

Less than 1.0 EU per μg of the rhTGFB1 by the LAL method.

>95% as determined by SDS-PAGE.

Lyophilized from 0.22 μm filtered solution in 0.085% TFA in 30% ACN. Normally trehalose is added as protectant before lyophilization.

See Certificate of Analysis for details of reconstitution instruction and specific concentration.

For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
-20°C to -70°C for 12 months in lyophilized state;
-70°C for 12 months under sterile conditions after reconstitution.

Please refer to product data sheet.


(1) Compromised glutathione synthesis results in high susceptibility to acetaminophen hepatotoxicity in acatalasemic mice
Ogino, Nagaoka, Tomizuka et al
Food Chem Toxicol (2021)
(2) PolyI:C suppresses TGF-β1-induced Akt phosphorylation and reduces the motility of A549 lung carcinoma cells
Yamaguchi, Yoshimura, Ohara et al
Mol Biol Rep (2021)
(3) Targeted truncated TGF-β receptor type II delivery to fibrotic liver by PDGFβ receptor-binding peptide modification for improving the anti-fibrotic activity against hepatic fibrosis in vitro and in vivo
Huang, Ding, Dong et al
Int J Biol Macromol (2021)
Showing 1-3 of 37108 papers.
Please refer to product data sheet.